STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13D] OWENS & MINOR INC/VA/ SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D

Rhea-AI Filing Summary

Owens & Minor (OMI): Coliseum Capital filed a Schedule 13D, replacing its prior 13G and signaling a more active posture. The reporting group—Coliseum Capital Management, Coliseum Capital, Coliseum Capital Partners, and principals Adam Gray and Christopher Shackelton—disclosed beneficial ownership of 13,100,807 shares, representing 16.9% of the common stock.

Coliseum states the stake was acquired for investment purposes and outlines potential actions under Item 4, including discussions with management and other stakeholders and evaluating proposals related to operations, governance, capitalization, business combinations, asset sales, or financing transactions. As context, Coliseum Capital Partners is the record owner of 10,657,337 shares and a separate account managed by Coliseum holds 2,443,470 shares. Shares outstanding were 77,346,594 as of October 24, 2025. The group reported no transactions in the 60 days preceding this filing.

Positive

  • None.

Negative

  • None.

Insights

13D signals activist flexibility with a 16.9% OMI stake.

Coliseum switched from 13G to 13D, disclosing 16.9% beneficial ownership (13,100,807 shares). A 13D permits engagement on strategy, governance, and capital structure, as reflected in Item 4’s menu of potential actions.

The filing notes record holdings of 10,657,337 shares at CCP and 2,443,470 shares in a separate account advised by CCM. Percentages are based on 77,346,594 shares outstanding as of October 24, 2025. The group reported no trades in the prior 60 days, which frames this as a position disclosure rather than a trading update.

Actual outcomes depend on future interactions with the company and other stakeholders. Subsequent disclosures may clarify any concrete proposals or governance changes.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


Coliseum Capital Management, LLC
Signature:/s/ Chivonne Cassar
Name/Title:Chivonne Cassar/Attorney-in-fact
Date:11/14/2025
Coliseum Capital, LLC
Signature:/s/ Chivonne Cassar
Name/Title:Chivonne Cassar/Attorney-in-fact
Date:11/14/2025
Coliseum Capital Partners, L.P.
Signature:/s/ Chivonne Cassar
Name/Title:Chivonne Cassar/Attorney-in-fact
Date:11/14/2025
Adam Gray
Signature:/s/ Chivonne Cassar
Name/Title:Chivonne Cassar/Attorney-in-fact
Date:11/14/2025
Christopher Shackelton
Signature:/s/ Chivonne Cassar
Name/Title:Chivonne Cassar/Attorney-in-fact
Date:11/14/2025

FAQ

What did Coliseum Capital disclose in its Schedule 13D on OMI?

Coliseum reported beneficial ownership of 13,100,807 shares of Owens & Minor common stock, equal to 16.9% of the class.

Why did Coliseum switch from a Schedule 13G to a 13D for OMI?

The filing states the group may no longer qualify to file on Schedule 13G and thus filed a Schedule 13D.

How many OMI shares are outstanding for the ownership calculation?

Percentages are based on 77,346,594 shares outstanding as of October 24, 2025.

How is Coliseum’s OMI stake allocated among entities?

CCP is the record owner of 10,657,337 shares, and a separate account advised by CCM holds 2,443,470 shares.

What actions might Coliseum consider regarding OMI?

Item 4 lists potential engagement on operations, strategy, governance, capitalization, and possible M&A or financing transactions.

Did Coliseum trade OMI shares recently?

The group reported no transactions in the 60 days preceding the filing.

Who are the individual reporting persons in the 13D?

Principals Adam Gray and Christopher Shackelton are included among the reporting persons.
Owens & Minor

NYSE:OMI

OMI Rankings

OMI Latest News

OMI Latest SEC Filings

OMI Stock Data

212.70M
74.52M
3.44%
100.24%
11.91%
Medical Distribution
Wholesale-medical, Dental & Hospital Equipment & Supplies
Link
United States
GLEN ALLEN